Understanding How Both Treatments Target Weight Loss
How Does Wegovy Work for Weight Loss Compared to Mounjaro's Mechanism?
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This prescription-only medicine works on brain appetite centres, potentially reducing food cravings and helping you feel satisfied longer. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors simultaneously, creating what researchers call a "dual incretin" approach to weight management. Both medications require weekly injections and work alongside lifestyle modifications to support sustainable weight loss.
The key difference lies in their receptor targets - whilst Wegovy focuses specifically on GLP-1 pathways that have been extensively studied since 2021, Mounjaro's dual-receptor approach represents a newer mechanism approved more recently. Both treatments must be prescribed by qualified healthcare professionals and require careful dose escalation over several months. Your prescriber at EverydayMeds can assess which mechanism may be more suitable based on your medical history, current medications, and weight management goals.
Wegovy vs Mounjaro Pricing: How Does Cost Affect Your Weight Loss Journey?
Understanding how Wegovy works for weight loss includes considering the financial investment required for long-term treatment. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with new customer code FIRST40 applied at checkout), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Intro Duo bundle (0.25mg & 0.5mg pens) costs £169.99, providing your first two months of treatment with convenient single delivery. For sustained weight management, our Ultimate Stability Trio offers three months of 2.4mg maintenance pens for £649.99.
Mounjaro follows a different pricing structure with six available doses ranging from 2.5mg to 15mg, reflecting its unique titration schedule. Both medications represent significant investments in your health, but the prescription-only nature ensures proper medical supervision throughout your weight loss journey. Returning customers benefit from code DOSE25 at checkout, making continued treatment more accessible. The key is choosing the medication whose mechanism and dosing schedule align best with your lifestyle and medical needs, rather than price alone.
Clinical Evidence: How Does Wegovy Work for Weight Loss in STEP Trials?
The STEP clinical trial programme demonstrates how Wegovy works for weight loss through rigorous scientific evidence. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. STEP 3 showed even greater results at approximately 16% when combined with intensive behavioural therapy, whilst STEP 5 demonstrated sustained clinically studied weight loss at two years.
Beyond weight management, the SELECT trial revealed that Wegovy may reduce major cardiovascular events by 20% (HR 0.80) in eligible patients. These results led to NICE recommendation TA875, approving Wegovy with specialist weight management support. Mounjaro's clinical programme (SURMOUNT trials) used different methodologies, making direct comparison inappropriate, but both treatments have demonstrated significant efficacy in their respective studies.
GLP-1 Mechanism: How Does Wegovy Work for Weight Loss at Cellular Level?
Wegovy works for weight loss by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone released by your intestines after eating. This mechanism targets specific receptors in your brain's appetite control centres, particularly the hypothalamus, reducing hunger signals and enhancing feelings of fullness. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Additionally, Wegovy may influence reward pathways associated with food cravings, potentially reducing the appeal of high-calorie foods. These combined effects create a comprehensive approach to appetite regulation that supports sustainable weight management when used alongside proper diet and exercise.
Ordering Process: How Does Wegovy Work Within Our Treatment Pathway?
Understanding how Wegovy works for weight loss begins with our streamlined 3-minute online clinical assessment, designed to evaluate your suitability for treatment. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), ensuring appropriate medical oversight before dispensing this prescription-only medicine. Once approved, your Wegovy pen ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and pharmaceutical standards. You'll receive detailed injection guidance, dose escalation schedules, and ongoing support to maximise treatment effectiveness whilst monitoring for any side effects.
Storage Advantages: How Does Wegovy Work Better for Travel Than Alternatives?
Wegovy's storage profile offers practical advantages for understanding how this treatment works within your lifestyle. Once removed from refrigeration, Wegovy pens remain stable for up to 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day limit. This extended stability makes Wegovy more convenient for business travel, holidays, or situations where refrigeration isn't consistently available. The FlexTouch pen design provides easy handling and accurate dosing, with clear dose markings and audible clicks confirming proper injection. Store unused pens in your fridge at 2-8°C, and remember that once you've used a pen, it can be kept at room temperature for its remaining doses within the 6-week window.
Wegovy vs Mounjaro: How Does Each Work for Different Patient Profiles?
Understanding how Wegovy works for weight loss versus Mounjaro requires considering individual patient factors beyond just mechanism of action. Wegovy's single-hormone approach may suit patients who prefer treatments with longer clinical track records and more predictable side effect profiles. The established dose escalation from 0.25mg to 2.4mg over 16 weeks provides gradual tolerance building that many patients find manageable. Mounjaro's dual-incretin approach might appeal to patients who haven't responded optimally to GLP-1-only treatments, though this requires careful medical assessment.
Both medications require commitment to lifestyle modifications and regular medical monitoring to achieve optimal results. Your medical history, current medications, previous weight loss attempts, and individual tolerance factors all influence which treatment mechanism may work best. Our prescribers evaluate these factors during clinical assessment, ensuring you receive the most appropriate recommendation rather than a one-size-fits-all approach to weight management.
Next Steps: How Does Wegovy Work Within Your Weight Loss Strategy?
Ready to understand how Wegovy works for weight loss in your specific situation? Both Wegovy and Mounjaro are available through EverydayMeds with full prescriber support and next-day delivery. New customers save with code FIRST40, whilst returning customers use DOSE25 at checkout for continued treatment affordability. Our clinical team provides ongoing support throughout your weight management journey, from initial assessment through maintenance dosing. Remember that both treatments work best alongside sustainable lifestyle changes - they're tools to support your efforts, not standalone solutions. Visit our weight loss collection to begin your clinical assessment, or speak with our prescribers about which mechanism might suit your individual needs and circumstances best. Start your assessment today and take the first step towards understanding which treatment could work for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
